USD 0.0
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2004 | -7.49 Million USD | 52.22% |
2003 | -15.68 Million USD | -22.7% |
2002 | -12.78 Million USD | -68.48% |
2001 | -7.58 Million USD | -86.61% |
2000 | -4.06 Million USD | -48.21% |
1999 | -2.74 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2005 Q3 | -2.47 Million USD | -18.0% |
2005 Q1 | -2.18 Million USD | 23.88% |
2005 Q2 | -2.09 Million USD | 4.05% |
2004 FY | -7.49 Million USD | 52.22% |
2004 Q4 | -2.87 Million USD | -60.17% |
2004 Q3 | -1.79 Million USD | -65.93% |
2004 Q2 | -1.08 Million USD | 38.26% |
2004 Q1 | -1.74 Million USD | 69.13% |
2003 Q2 | -3.94 Million USD | -22.04% |
2003 Q4 | -5.66 Million USD | -99.03% |
2003 Q1 | -3.22 Million USD | 19.33% |
2003 Q3 | -2.84 Million USD | 27.72% |
2003 FY | -15.68 Million USD | -22.7% |
2002 Q4 | -4 Million USD | -28.13% |
2002 Q3 | -3.12 Million USD | 1.06% |
2002 Q1 | -2.49 Million USD | -7.52% |
2002 Q2 | -3.15 Million USD | -26.33% |
2002 FY | -12.78 Million USD | -68.48% |
2001 FY | -7.58 Million USD | -86.61% |
2001 Q4 | -2.32 Million USD | -21.39% |
2001 Q3 | -1.91 Million USD | -9.16% |
2001 Q2 | -1.75 Million USD | -10.11% |
2001 Q1 | -1.59 Million USD | -23.41% |
2000 Q1 | -807.93 Thousand USD | 0.0% |
2000 Q2 | -973 Thousand USD | -20.43% |
2000 Q3 | -993.93 Thousand USD | -2.15% |
2000 Q4 | -1.29 Million USD | -29.9% |
2000 FY | -4.06 Million USD | -48.21% |
1999 FY | -2.74 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
American Medical Technologies Inc. | 1.16 Million USD | 743.798% |
Ansell Limited | 129.3 Million USD | 105.797% |
Ansell Limited | 129.3 Million USD | 105.797% |
BG Medicine, Inc. | - USD | Infinity% |
Biotage AB (publ) | 31.13 Million USD | 124.071% |
BioLife Sciences Inc. | - USD | Infinity% |
CB Scientific, Inc. | -1.59 Million USD | -369.714% |
Psykey, Inc. | -797.5 Thousand USD | -839.836% |
ConvaTec Group Plc | 262.7 Million USD | 102.853% |
ConvaTec Group Plc | 262.7 Million USD | 102.853% |
Encision Inc. | -640.78 Thousand USD | -1069.698% |
Golden Valley Development, Inc | -141.81 Thousand USD | -5185.402% |
Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -6718.182% |
Innovative MedTech Inc. | -4.27 Million USD | -75.365% |
Medite Cancer Diagnostics, Inc. | -6.48 Million USD | -15.667% |
Paradigm Medical Industries, Inc. | 330 Thousand USD | 2371.281% |
QuantRx Biomedical Corporation | - USD | Infinity% |
Remedent, Inc. | -122.89 Thousand USD | -5999.136% |
Reflect Scientific, Inc. | -467.27 Thousand USD | -1504.019% |
SmileDirectClub, Inc. | -241.15 Million USD | 96.892% |
Sector 10, Inc. | -39.84 Thousand USD | -18711.435% |
Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 102.345% |
SheerVision, Inc. | 155.72 Thousand USD | 4913.087% |
United Health Products, Inc. | -2.42 Million USD | -208.886% |
Vasamed, Inc. | 4.74 Million USD | 258.05% |
Wearable Health Solutions, Inc. | -2.29 Million USD | -226.712% |
Yubo International Biotech Limited | -1.2 Million USD | -521.896% |